Whom to Biopsy Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators

被引：19

作者：

Loeb, Stacy ^{[1
,2
,3
]}

Dani, Hasan ^{[4
]}

机构：

[1] NYU, Dept Urol, New York, NY USA

[2] NYU, Dept Populat Hlth, New York, NY USA

[3] Manhattan Vet Affairs Med Ctr, Dept Urol, New York, NY USA

[4] SUNY, Downstate Coll Med, Dept Urol, Brooklyn, NY USA

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2017年 / 44卷 / 04期

关键词：

Prostate cancer; Prostate-specific antigen; Biomarkers; Prostate biopsy; Nomograms; PROSTATE HEALTH INDEX; CANCER ANTIGEN 3; MOLECULAR URINE ASSAY; HIGH-GRADE CANCER; RADICAL PROSTATECTOMY; CLINICAL-PERFORMANCE; INTERNAL VALIDATION; EXTERNAL VALIDATION; ACTIVE SURVEILLANCE; KALLIKREIN MARKERS;

D O I：

10.1016/j.ucl.2017.07.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

This article describes markers used for prostate biopsy decisions, including prostrate-specific antigen (PSA), free PSA, the prostate health index, 4Kscore, PCA3, and ConfirmMDx. It also summarizes the use of nomograms combining multiple variables for prostate cancer detection.

引用

页码：517 / +

页数：9

共 50 条

[31] Role of biomarkers in diagnostics, stratification of risk and prognosis of heart failure
Khanyukov, O. O.
Sapozhnychenko, L., V
MEDICNI PERSPEKTIVI, 2018, 23 (02): : 56 - 63
[32] Clinical utility of novel biomarkers for cardiovascular disease risk stratification
Averna, Maurizio
Noto, Davide
INTERNAL AND EMERGENCY MEDICINE, 2012, 7 : S263 - S270
[33] Risk stratification for bladder cancer: Biomarkers of inflammation and immune activation
Nabavizadeh, Reza
Bobrek, Katherine
Master, Viraj A.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (09) : 706 - 712
[34] Editorial: Epigenetic biomarkers for cancer risk stratification and patient management
Tanic, Miljana
Ecker, Simone
Lyskjaer, Iben
FRONTIERS IN GENETICS, 2024, 15
[35] Clinical utility of novel biomarkers for cardiovascular disease risk stratification
Maurizio Averna
Davide Noto
Internal and Emergency Medicine, 2012, 7 : 263 - 270
[36] Clinical indices and biomarkers for perioperative cardiac risk stratification: an update
Jankovic, Radmilo J.
Markovic, Danica Z.
Sokolovic, Dusan T.
Zdravkovic, Ivana
Sorbello, Massimiliano
MINERVA ANESTESIOLOGICA, 2017, 83 (04) : 392 - 401
[37] The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome
Chacko, Sanoj
Haseeb, Sohaib
Glover, Benedict M.
Wallbridge, David
Harper, Alan
FUTURE SCIENCE OA, 2018, 4 (01):
[38] Combination of conventional biomarkers for risk stratification in chronic heart failure
Niizeki, Takeshi
Takeishi, Yasuchika
Kitahara, Tatsuro
Suzuki, Satoshi
Sasaki, Toshiki
Ishino, Mitsunori
Kubota, Isao
JOURNAL OF CARDIOLOGY, 2009, 53 (02) : 179 - 187
[39] The role of biomarkers in risk stratification, treatment and outcome in acute GVHD
Kaviany, Saara
Kitko, Carrie L.
CURRENT OPINION IN HEMATOLOGY, 2021, 28 (06) : 401 - 407
[40] Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer
Basourakos, Spyridon P.
Tzeng, Michael
Lewicki, Patrick J.
Patel, Krishnan
Al Awamlh, Bashir Al Hussein
Venkat, Siv
Shoag, Jonathan E.
Gorin, Michael A.
Barbieri, Christopher E.
Hu, Jim C.
FRONTIERS IN ONCOLOGY, 2021, 11

← 1 2 3 4 5 →